Union League Life Science Club
The IPO Journey: a Two-Part Series
Part 1: Agile Therapeutics’ Acquisition Journey
Date: Wednesday, February 26
Time: 5:30 PM
Location: Union League of Philadelphia
140 S Broad St, Philadelphia, PA 19102
You will hear an introspective on how a small publically-held pharma company, Agile Therapeutics, got acquired by an international pharma company, Insud Pharma. Our guests will be the CEO, Al Altomari, and Head of Investor Relations, Matt Riley, from Agile Therapeutics. The conversation will focus on managed investors and analysts on the idea of a sale, the buyers, and the acquisition process.
Part 2: Navigating the Pros and Cons of Pharma IPOs. Wednesday, March 19
